Bicarbonate

Bicarbonate

SCHEMBL216839

O=C([O-])[O-].[Ba+2].[Pd]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL11358653 0.94 CA4 (0.50)
Bicarbonate SCHEMBL18155 0.94
Bicarbonate SCHEMBL1331862 0.94
Bicarbonate SCHEMBL2364135 0.88
Bicarbonate SCHEMBL3238836 0.88 CA4 (0.46)
Bicarbonate SCHEMBL9503548 0.88
Bicarbonate SCHEMBL7516959 0.88 CA4 (0.46)
Bicarbonate SCHEMBL8954332 0.88 CA4 (0.46)
Bicarbonate SCHEMBL1870014 0.88 CA4 (0.46)
Bicarbonate SCHEMBL4588623 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 205 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1764376-A Reduction amination by levulinic acid and nitro compound is produced 5-methyl-N-aryl-2-Pyrrolidone and 5-methyl-N-alkyl-2-Pyrrolidone DU PONT (US) 2006-04-26 CN claimed
CN-1214023-C Process for producing benzo-fused heterocycle MERCK PATENT GMBH (DE) 2005-08-10 CN claimed
CN-1422265-A Process for producing benzo-fused heterocycle MERCK PATENT GMBH (DE) 2003-06-04 CN claimed
US-20260108497-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICALC., LTD. (JP) 2026-04-23 US disclosed
US-20240148699-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2024-05-09 US disclosed
US-20220265613-A1 OXAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-08-25 US disclosed
US-11273168-B2 Methods of treating anxiety by administering a substituted quinolone OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2022-03-15 US disclosed
US-11214559-B2 Method for producing 2,5-bis(aminomethyl)furan MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2022-01-04 US disclosed
EP-3696173-B1 METHOD FOR PRODUCING 2,5-BIS(AMINOMETHYL) TETRAHYDROFURAN MITSUBISHI GAS CHEMICAL CO (JP) 2021-12-22 EP disclosed
EP-3656766-B1 METHOD FOR PRODUCING 2,5-BIS(AMINOMETHYL)FURAN MITSUBISHI GAS CHEMICAL CO (JP) 2021-09-15 EP disclosed
US-20210221782-A1 METHOD FOR PRODUCING 2,5-BIS(AMINOMETHYL)TETRAHYDROFURAN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-07-22 US disclosed
US-4524028-A PENICILLINS CIBA-GEIGY CORPORATION (US) 1985-06-18 US disclosed
US-4518533-A Azetidinone-4-disulfides as intermediates for thia-aza compounds with a beta-lactam ring CIBA GEIGY CORPORATION (US) 1985-05-21 US disclosed
US-4515717-A INTERMEDIATES FOR 6-UNSUBSTITUTED PENICILLIN ANTIOBIOTICS CIBA GEIGY CORPORATION (US) 1985-05-07 US disclosed
US-4500457-A TREATING AN ACYLOXYAZETIDINONE WITH MERCAPTO COMPOUND, GLYOYLIC ESTER, HALOGENATION AGENT, AND PHOSPHINE COMPOUNT THEN CYCLIZATION CIBA-GEIGY CORPORATION (US) 1985-02-19 US disclosed
US-4447360-A Intermediates for thia-aza compounds with a β-lactam ring CIBA-GEIGY CORPORATION (US) 1984-05-08 US disclosed
US-4331676-A 2-PENEM COMPOUNDS UNSUBSTITUTED IN THE 6 POSITION CIBA-GEIGY CORPORATION (US) 1982-05-25 US disclosed
US-4220587-A BACTERICIDES MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) 1980-09-02 US disclosed
US-4179437-A Amino acid derivatives of 6-(2-amino-2-arylacetamido) penicillanic acids MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1979-12-18 US disclosed
US-4111932-A BACTERICIDE MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1978-09-05 US disclosed